Can-Fite Biopharma Ltd Sponsored ADR (Israel)Live Price
$2.00 USDNovember 21, 2024, 9:35 am UTC Add to Watchlist Create Price Alert
Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) - Live Price
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) is a publicly traded company based in Israel that specializes in the development of innovative treatments for various cancers. The company's lead product, Piccolo, is in advanced clinical trials for the treatment of advanced liver cancer, with promising results thus far. Can-Fite's pipeline also includes other early-stage drug candidates, such as Namodenoson for the treatment of non-small cell lung cancer and AMD3100 for the treatment of various solid tumors. Investors interested in the biotechnology sector and cancer treatment innovations should consider CANF as a potential addition to their portfolio, given its promising clinical developments and potential for innovative treatments in the oncology field.
Get Can-Fite Biopharma Ltd Sponsored ADR (Israel) Price Change Alerts
Verdasi can notify you when CANF goes up or down. Get a text message or email when Can-Fite Biopharma Ltd Sponsored ADR (Israel) changes in price.
Setup CANF Price AlertsHow Many People are employed by Can-Fite BioPharma Ltd.?
How much is Can-Fite Biopharma Ltd Sponsored ADR (Israel) stock worth?
Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF) is worth $2.00 USD as of November 21, 2024, 9:35 am UTC time.
View the interactive graph to see how much Can-Fite Biopharma Ltd Sponsored ADR (Israel) has changed in the last hour or historically.
Keep learning about stocks:
Day trading has never been more accessible as a Canadian, with no minimum requirements, and the introduction of commission free trades. Learn how to day trade in Canada.
Have you wondered what a day trader is? Understand the strategies behind day trading, and how professionals traders make their living as a day trader.
When placing your trades, commissions can cut into your expected returns if you're not diligent about minimizing or eliminating trading fees entirely. Learn how!